Meeting
2023 ASCO Breakthrough
A novel non-invasive multi-target stool DNA methylation assay for early detection of gastrointestinal cancers.
Authors
Li-Yue Sun
Second Department of Oncology, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China
Li-Yue Sun , Ju Shen , Yu-Yun Zhong , Jiao-Jiao Yang , Yu-Ying Jiang , Yan-Jun Cheng , Xi-Ying Wang , Rui-Qi Wang , Fei Liu , Fang Liu , Meng-Jin Chen , Xiao-Mei Ling , Jie-Lun Wen , Fang Wang , Xu-Hui Zhang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Gastrointestinal Cancer,Gynecologic Cancer,Head and Neck Cancer,Quality of Care,Genetics/Genomics/Multiomics,Healthcare Equity and Access to Care,Healthtech Innovations,Models of Care and Care Delivery,Population Health,Viral-Mediated Malignancies
Sub Track
Early Detection and Surveillance
Citation
JCO Global Oncology 9, 2023 (suppl 1; abstr 41)
DOI
10.1200/GO.2023.9.Supplement_1.41
Abstract #
41
Poster Bd #
B8
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
A novel cell-free multi-omics approach for enhancing multi-cancer early detection.
First Author: Thien-Chi Van Van Nguyen
Poster
2024 ASCO Annual Meeting
High-sensitive multi-cancers early detection for 8 cancer types by cell-free DNA targeted methylation sequencing: A retrospective cohort study.
First Author: Huiyan Luo
Poster
2023 ASCO Annual Meeting
Real-world performance of a multi-cancer early detection test based on integrative analysis of cell-free DNA whole-methylome sequencing.
First Author: Yulong LI
Poster
2018 Gastrointestinal Cancers Symposium
Enrollment of esophago-gastric cancer patients in a clinical fast-track program and it’s affect on time to treatment and quality of life.
First Author: Atuhani S. Burnett